SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shilpa Medicare informs about conference call

06 Aug 2025 Evaluate
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shilpa Medicare that it enclosed the schedule of Q1 FY2025-26 Earnings Conference Call, which is to be held on Wednesday, August 13, 2025, at 17.00 hrs. A copy of this intimation is also being made available at: https://www.vbshilpa.com/investor-presentation.php.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

408.30 3.40 (0.84%)
22-Apr-2026 12:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1661.70
Dr. Reddys Lab 1223.70
Cipla 1235.95
Zydus Lifesciences 929.60
Lupin 2316.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×